Bulletin
Investor Alert

New York Markets Open in:

Bayer AG ADR

OTC: BAYRY

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Oct 27, 2020, 3:59 p.m.

/zigman2/quotes/203424967/delayed

$

12.28

Change

-0.32 -2.54%

Volume

Volume 690,165

Quotes are delayed by 20 min

/zigman2/quotes/203424967/delayed

Previous close

$ 12.60

$ 12.28

Change

-0.32 -2.54%

Day low

Day high

$12.28

$12.45

Open

52 week low

52 week high

$12.28

$21.49

Open

Company Description

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in...

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Valuation

P/E Current

10.21

P/E Ratio (without extraordinary items)

17.47

Price to Sales Ratio

1.64

Price to Book Ratio

1.51

Price to Cash Flow Ratio

10.41

Enterprise Value to EBITDA

11.75

Enterprise Value to Sales

2.42

Total Debt to Enterprise Value

0.37

Efficiency

Revenue/Employee

419,412.00

Income Per Employee

23,222.00

Receivables Turnover

3.09

Total Asset Turnover

0.33

Liquidity

Current Ratio

1.37

Quick Ratio

0.90

Cash Ratio

0.23

Profitability

Gross Margin

59.89

Operating Margin

10.38

Pretax Margin

6.25

Net Margin

5.54

Return on Assets

1.84

Return on Equity

5.17

Return on Total Capital

5.20

Return on Invested Capital

2.87

Capital Structure

Total Debt to Total Equity

82.33

Total Debt to Total Capital

45.15

Total Debt to Total Assets

29.67

Long-Term Debt to Equity

77.97

Long-Term Debt to Total Capital

42.77

Officers and Executives

Name Age Officer Since Title
Dr. Norbert Winkeljohann 62 2018 Member-Supervisory Board
Mr. Werner Baumann 57 1988 Principal
Mr. Wolfgang U. Nickl 50 2018 Member-Management Board
Mr. Bijoy Sagar 50 2020 Chief Information Technology Officer
Ms. Marianne de Backer 50 2019 Head-Licensing Pharmaceuticals Division

Insider Actions

– Purchase – Sale 1 – Number of Transactions
/news/latest/company/us/bayry

MarketWatch News on BAYRY

  1. Bayer Is Betting on Gene Therapy With a $4 Billion U.S. Acquisition

    11:37 a.m. Oct. 26, 2020

    - Barron's Online

  2. Bayer to pay up to $4 billion for Asklepios Bio

    3:43 a.m. Oct. 26, 2020

    - MarketWatch.com

  3. Bayer late lymphoma study meets primary endpoint

    3:07 a.m. Oct. 14, 2020

    - MarketWatch.com

  4. Stocks Close Up Slightly as Stimulus Talks Falter

    4:13 p.m. Oct. 1, 2020

    - Barron's Online

  5. Bayer unveils billions in new cost cuts

    8:21 p.m. Sept. 30, 2020

    - MarketWatch.com

  6. Bayer extends CEO's contract

    1:37 a.m. Sept. 11, 2020

    - MarketWatch.com

  7. Dow Turns Positive for the Year as the Dollar Falls

    4:41 p.m. Aug. 28, 2020

    - Barron's Online

  8. The Dow Is Up Because Consumers Are Still Spending

    12:46 p.m. Aug. 28, 2020

    - Barron's Online

  9. Bayer: Prostate cancer drug approved in China

    3:57 a.m. Aug. 27, 2020

    - MarketWatch.com

  10. Why Dell Stock Can Gain 42%: Portfolio Manager

    9:56 a.m. Aug. 21, 2020

    - Barron's Online

  11. Bayer reports $11.2 bln loss on Roundup costs

    2:18 a.m. Aug. 4, 2020

    - MarketWatch.com

  12. Bayer loses Roundup appeal, but damages slashed

    10:50 p.m. July 20, 2020

    - MarketWatch.com

  13. Bayer shares climb after $11B roundup settlement

    4:11 a.m. June 25, 2020

    - MarketWatch.com

  14. Bayer settles Roundup lawsuits for $10.9 million

    7:07 p.m. June 24, 2020

    - MarketWatch.com

  15. Loading more headlines...
/news/nonmarketwatch/company/us/bayry

Other News on BAYRY

  1. EPA OKs use of Bayer weedkiller for five years

    6:31 p.m. Oct. 27, 2020

    - Seeking Alpha

  2. Bayer (BAYRY) to Report Q3 Earnings: What's in the Cards?

    10:31 a.m. Oct. 27, 2020

    - Zacks.com

  3. Bayer: Consider The Company At Dirt-Cheap Valuation

    10:14 a.m. Oct. 27, 2020

    - Seeking Alpha

  4. Wide-Moat Stocks On Sale - The November 2020 Heat Map

    10:27 a.m. Oct. 26, 2020

    - Seeking Alpha

  5. Wall Street Breakfast: Flurry Of Dealmaking

    7:13 a.m. Oct. 26, 2020

    - Seeking Alpha

  6. Bayer to acquire Asklepios Bio for $4B

    4:25 a.m. Oct. 26, 2020

    - Seeking Alpha

  7. Bayer Stock: Latest Events Support My Neutral Rating

    3:13 p.m. Oct. 23, 2020

    - Seeking Alpha

  8. 7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio

    2:05 p.m. Oct. 23, 2020

    - InvestorPlace.com

  9. Bayer extends decline after losing another weedkiller case

    10:19 a.m. Oct. 21, 2020

    - Seeking Alpha

  10. Foghorn Therapeutics Files Terms For $120 Million IPO

    2:25 p.m. Oct. 19, 2020

    - Seeking Alpha

  11. Bayer's Aliqopa Meets Primary Endpoint in Lymphoma Study

    10:24 a.m. Oct. 15, 2020

    - Zacks.com

  12. Bayer: 3 Ways To Value The Company

    1:47 a.m. Oct. 15, 2020

    - Seeking Alpha

  13. September 2020 Dividend Portfolio Update

    6:43 a.m. Oct. 12, 2020

    - Seeking Alpha

  14. Bayer: Bear Vs. Bull

    5:00 p.m. Oct. 11, 2020

    - Seeking Alpha

  15. Bayer, BASF Fight to Keep Weedkiller on U.S. Farms

    11:00 a.m. Oct. 11, 2020

    - Jacob Bunge

  16. Loading more headlines...

At a Glance

Bayer AG

Kaiser-Wilhelm-Allee 1

Leverkusen, Nordrhein-Westfalen 51368

Phone

49 214301

Industry

Pharmaceuticals

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$43.55B

Net Income

$2.41B

2019 Sales Growth

10.0%

Employees

103,824

/news/pressrelease/company/us/bayry

Press Releases on BAYRY

  1. Loading more headlines...
Link to MarketWatch's Slice.